Pfizer Inc PFE:NYSE

Earnings Announcement Next Ex-Dividend date is expected on 01/27/2022
Last Price$53.58Cboe Real-Time Last Sale as of 3:48PM ET 1/27/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.97(1.84%)
Bid (Size)$53.57 (527)
Ask (Size)$53.59 (501)
Day Low / High$53.00 - 54.58
Volume26.8 M

View Pharmaceuticals: Major IndustryPeer Comparison as of 01/27/2022


Pfizer Inc ( NYSE )

Price: $53.58
Change: +0.97 (1.84%)
Volume: 26.8 M
3:48PM ET 1/27/2022

Abbvie Inc ( NYSE )

Price: $136.56
Change: +2.33 (1.74%)
Volume: 7.2 M
3:47PM ET 1/27/2022

Eli Lilly and Co ( NYSE )

Price: $237.15
Change: -0.71 (0.30%)
Volume: 1.6 M
3:47PM ET 1/27/2022

Merck & Co Inc ( NYSE )

Price: $80.71
Change: +1.57 (1.98%)
Volume: 13.0 M
3:47PM ET 1/27/2022

Johnson & Johnson ( NYSE )

Price: $170.65
Change: +2.27 (1.35%)
Volume: 5.9 M
3:48PM ET 1/27/2022

Read more news Recent News

Pfizer Says Paxlovid COVID-19 Pill Received Positive Opinion From European Medicines Agency Committee
10:40AM ET 1/27/2022 MT Newswires

Pfizer (PFE) said Thursday the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending...

COVID-19 Severity Appears Lower With Omicron, But High Hospitalization Volume Could Strain US Healthcare System, CDC Report Suggests
3:52AM ET 1/26/2022 MT Newswires

COVID-19 severity appears lower with the omicron variant of the coronavirus but the high volume of emergency department visits and hospitalization could...

US Labor Department's OSHA Revokes COVID-19 Vaccination Order for Large Employers
2:13PM ET 1/25/2022 MT Newswires

The US Department of Labor's Occupational Safety and Health Administration, or OSHA, said Tuesday it is withdrawing a Nov. 5 order that required large...

Pfizer, BioNTech Launch Clinical Study of Omicron-Specific COVID-19 Vaccine
12:34PM ET 1/25/2022 MT Newswires

Pfizer (PFE) and BioNTech (BNTX) have launched a clinical trial of their COVID-19 vaccine that targets the highly infectious omicron variant of the virus...

View all Commentary and Analysis

Best Growth Stocks to Buy for January 27th
8:14AM ET 1/27/2022 Zacks

TOL, PFE, and M made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 27, 2022

Best Growth Stocks to Buy for January 27th
8:14AM ET 1/27/2022 Zacks

TOL, PFE, and M made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 27, 2022

Upcoming Ex-Dividend Dates: January 27-February 9, 2022
4:03AM ET 1/27/2022 Seeking Alpha

LABU - A Compelling Biotech Trade
4:24PM ET 1/26/2022 Seeking Alpha

Company Profile

Business DescriptionPfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY. View company web site for more details
Address235 East 42nd Street
New York, New York 10017-5755
Number of Employees92,400
Recent SEC Filing01/14/20224
Chairman, Chief Executive & Operating OfficerAlbert Bourla
President & General Manager-Pfizer VaccinesSusan Silbermann
Chief Financial Officer & EVP-Global SupplyFrank A. D'Amelio
Chief Scientific Officer & Research PresidentMikael Dolsten

Company Highlights

Price Open$53.02
Previous Close$52.61
52 Week Range$33.36 - 61.71
Market Capitalization$300.7 B
Shares Outstanding5.6 B
SectorHealth Technology
IndustryPharmaceuticals: Major
Current Dividend / Yield$0.40 / 3.02%
Dividend Ex-Date01/27/2022
Dividend Pay-Date03/04/2022
Dividend Yield 5 Year Average3.66%
Next Earnings Announcement02/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings15.71
Earnings per Share$3.66
Beta vs. S&P 500N/A
Revenue$53.6 B
Net Profit Margin27.26%
Return on Equity27.23%

Analyst Ratings as of 01/23/2022

Consensus RecommendationConsensus Icon
Powered by Factset